Hepatitis C symptoms and diagnosis: latest news

Hepatitis C symptoms and diagnosis resources

  • Hepatitis C

    A blood test for antibodies will show if you have been exposed to hepatitis C.HIV treatment has particular benefits for people with HIV and hepatitis...

    From: Factsheets

    Information level Level 2
  • Hepatitis C

    Hepatitis C can cause the same types of symptoms and long-term liver damage as hepatitis B, though the two viruses are not related. Recent estimates find that...

    From: Booklets

    Information level Level 2
  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1

Hepatitis C symptoms and diagnosis features

Hepatitis C symptoms and diagnosis in your own words

Hepatitis C symptoms and diagnosis news from aidsmap

More news

Hepatitis C symptoms and diagnosis news selected from other sources

  • Long-term antibiotic prophylaxis reduces mortality in people with advanced liver disease

    A multicenter, randomized, controlled study presented today found that long-term oral antibiotic therapy with norfloxacin improved the prognosis of people with life-threatening advanced liver disease. The study, presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, showed that norfloxacin administration for six months was associated with a reduced risk of death and infection at six months in patients with Child-Pugh class C cirrhosis, a very severe and advanced stage of liver disease.

    20 April 2017 | EASL press release
  • HCV Infection Linked to Nonhepatic Cancers in the Elderly

    Hepatitis C virus (HCV) infection may be linked to cancers other than hepatocellular carcinoma (HCC), such as bile duct cancers and diffuse large B-cell lymphoma (DLBCL), according to a study published in Cancer.

    21 February 2017 | Infectious Disease Advisor
  • HCV Screening Shouldn't Just Focus on At-Risk Populations

    At the Conference on Retroviruses and Opportunistic Infections (CROI 2017) in Seattle, Washington, researchers from MedStar Health Research Institute in Maryland presented new data on hepatitis C virus (HCV)-positive non-baby boomers.

    21 February 2017 | Contagion Live
  • WHO guidelines on hepatitis B and C testing

    These are the first WHO guidelines on testing for chronic HBV and HCV infection and complement published guidance by WHO on the prevention, care and treatment of chronic hepatitis C and hepatitis B infection. These guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are intended for use across age groups and populations.

    21 February 2017 | World Health Organization
  • Bridging gaps in hepatitis C awareness and diagnosis

    If ever there was an area of healthcare where place-based care could have a major impact on local public health gains it is the identification and treatment of hepatitis C virus (HCV) infected patients. However the same reasons that point to place-based health systems being of value for this condition also make it one of the most difficult challenges to take on. If place-based care can be made to work for treating HCV it can be made to work across the system.

    10 February 2017 | New Local Government Network
  • Initial HCV test results are false positive in almost half of general population

    Nearly half of patients in the general population who test positive for hepatitis C virus (HCV) do not have the disease, according to Dr. Anne Moorman and her associates.

    08 February 2017 | Family Practice News
  • First WHO prequalified hepatitis C rapid test opens the door to expanded treatment

    WHO has just prequalified its first hepatitis C virus (HCV) rapid diagnostic test, a tool that will aid diagnosis of HCV in low- and middle-income countries and improve access to treatment.

    05 December 2016 | World Health Organization
  • A promising Hep C program seems to be working — and it could be a model for other countries

    Georgia, a country nestled against the Black Sea between Turkey and Russia with a population of 3.7 million, has since taken on a public health effort to help reduce its prevalence of hepatitis C (HCV for short) by 90% by 2020.

    24 October 2016 | Business Insider
  • Study Finds Patients with Hepatitis C Have Higher Hospitalization Rate

    A study that explored the healthcare burden of chronic infection of the hepatitis C virus found that patients with the disease were more than 3 times likely to be hospitalized than patients in a comparison group.

    31 May 2016 | MD Magazine
  • Primrose Healthcare Launches an Innovative Alcohol App to Help Hepatitis C Patients Overcome Alcohol Addiction

    Leveraging mobile technology and powered by Here and Now Systems, the alcohol app provides personalized education and resources through goal setting, alerts, coaching, and ongoing feedback to better engage and support hepatitis C patients on their journey toward alcohol addiction recovery.

    24 May 2016 | Business Wire (press release)
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.